Avicanna sales flat in the third quarter, cash concerns persist | Where to buy Skittles Moonrock online

Learn how to buy cannabis online. TOP QUALITY GRADE A++

Cannabyss Inc. is the best place online to buy top quality weed, cannabis, vape, marijuana and CBD products. Get your borderless orders delivered at the pickup spot with ease. Top Grade products for client satisfaction.

👉 Click here to Visit our shop! 🛒

Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) managed to lift its margins while posting flat revenue in the third quarter as summer sales slowed.

Revenue reached C$6.3 million for the three months ended Sept. 30, a marginal 0.34% increase from C$6.25 million in the same period last year, according to the results Thursday.

The Toronto-based company saw its gross margin percentage climb to 57% during the quarter, up from 46% a year earlier, reflecting what CEO Aras Azadian called “progressive improvements” across operations.

“We are now better positioned to turn our attention towards our international growth initiatives,” Azadian said in a statement.

The company’s adjusted EBITDA loss narrowed to C$293,931 in the third quarter, marking a 38% improvement from a C$473,650 loss in the year-ago quarter. Operating expenses ticked up slightly to C$4.35 million versus C$4.21 million.

North American operations, which include the MyMedi.ca platform acquired from Shoppers Drug Mart last year, generated C$5.53 million in the third-quarter revenue. The company noted slower summer sales in August and September versus 2023. South American revenue, primarily from Colombian operations, jumped to C$740,328 from C$105,613 a year earlier.

During the third quarter, Avicanna fully repaid approximately C$1.3 million in outstanding principal on non-convertible debentures. However, liquidity remains tight with C$812,068 in cash as of quarter-end.

The company completed a private placement in August, raising net proceeds of C$1.93 million through the sale of units at C$0.30 each. The funds were earmarked for general working capital and the MyMedi.ca platform.